118685-91-9 Usage
Uses
Used in Pharmaceutical Industry:
SARCOSINE-METHYL-D3 is used as a therapeutic agent for the treatment of schizophrenia. It functions as a type 1 glycine transporter inhibitor and a glycine agonist, which may help alleviate the symptoms of the disorder.
Used in Diagnostics and Research:
SARCOSINE-METHYL-D3 is used as a marker for prostate cancer aggression. Its presence can indicate the severity and progression of the disease, aiding in the diagnosis and monitoring of prostate cancer.
Used in Synthesis of Labelled Compounds:
SARCOSINE-METHYL-D3 is used as an intermediate in the synthesis of Creatinine-d3 (C781502), a labeled Creatinine. This labeled compound is valuable in research and diagnostics, as it can be used to study the metabolism and excretion of creatine in various biological systems.
Used in Urine Analysis:
Creatinine-d3, synthesized using SARCOSINE-METHYL-D3, is a normal constituent of urine. It can be found in all soils, grain seeds, and other vegetable matter, as well as in certain fish and crab meat extract. The analysis of Creatinine-d3 can provide insights into the health of an individual, particularly in relation to kidney function and muscle metabolism.
Check Digit Verification of cas no
The CAS Registry Mumber 118685-91-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,6,8 and 5 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 118685-91:
(8*1)+(7*1)+(6*8)+(5*6)+(4*8)+(3*5)+(2*9)+(1*1)=159
159 % 10 = 9
So 118685-91-9 is a valid CAS Registry Number.
InChI:InChI=1/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6)/i1D3
118685-91-9Relevant academic research and scientific papers
MAGNETIC RESONANCE IMAGING DRUG CONTAINING DEUTERATED SARCOSINE, AND DIAGNOSTIC METHOD USING SAID DRUG
-
Paragraph 0084, (2021/11/04)
The invention relates to the means for magnetic resonance imaging of oncological diseases and other diseases, accompanied by a locally altered level of absorption of nutrients by cells. The invention is the diagnostic drug containing at least one deuterated derivative of sarcosine, as well as the diagnostic method based on the use of this diagnostic drug. The method of the invention includes performing magnetic resonance imaging and / or deuterium magnetic resonance spectroscopy after administration of the diagnostic drug in a time sufficient for the accumulation of the diagnostic drug in a target area of a subject's body. The proposed method allows to carry out a highly informative diagnostics of oncological diseases and other diseases, accompanied by a locally altered level of absorption of nutrients by cells.
